Bibliography
Found 36 results
Filters: Keyword is Anti-Retroviral Agents [Clear All Filters]
Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART. J Neurovirol. 2014 ;20(3):294-303.
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 ;17(3):248-57.
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.
Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745
. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS (London, England) [Internet]. 2007 ;21:1877-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17721095
Is the glass three-quarters full or one-quarter empty?. J Infect Dis. 2006 ;194(12):1628-31.
. Human immunodeficiency virus and the central nervous system. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases [Internet]. 2006 ;10:41-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16767315
. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. Journal of Neuroimmunology [Internet]. 2006 ;179:180-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16901548
.